OBJECTIVE: To characterize HIV-1 strains in a potential vaccine trial cohort (CODE) in the Mbeya region of southwest Tanzania. DESIGN: Study volunteers (n = 3096) were recruited from urban areas in Mbeya Town, using two different recruitment strategies, and in a nearby rural village. METHODS: Cryopreserved plasma from 507 HIV-1 prevalent cases was the source of viral RNA for HIV-1 genotyping by the Multi-region Hybridization Assay, the MHA(acd), and selected strains were confirmed by complete genome sequencing. RESULTS: The overall HIV-1 prevalence was 16.6% [95% confidence interval (CI), 15.3-17.9] within the cohort. HIV-1 prevalence was higher among women, and in urban areas. Recruitment through advertisement targeted a high-risk urban male population for HIV-1 infection [adjusted odds ratio (adj. OR), 1.68; 95% CI, 1.13-2.51] when compared with men recruited door-to-door. The complexity of the HIV-1 epidemic was also higher in urban areas evidenced by the high-risk of HIV-1 infection with a recombinant strain (adj. OR, 2.69; 95% CI, 1.08-6.69) and HIV-1 dual infection (adj. OR, 5.16; 95% CI, 1.07-24.9), mainly driven by urban men recruited through advertisement. CONCLUSIONS: Overall the urban epidemic was more genetically complex, with higher prevalence and more recombinants and dual infections. Vaccine trials in Mbeya region can assess a complex HIV-1 population dynamic and determine vaccine efficacy in relationship to the genetic diversity of HIV-1 strains that challenge vaccines.
OBJECTIVE: To characterize HIV-1 strains in a potential vaccine trial cohort (CODE) in the Mbeya region of southwest Tanzania. DESIGN: Study volunteers (n = 3096) were recruited from urban areas in Mbeya Town, using two different recruitment strategies, and in a nearby rural village. METHODS: Cryopreserved plasma from 507 HIV-1 prevalent cases was the source of viral RNA for HIV-1 genotyping by the Multi-region Hybridization Assay, the MHA(acd), and selected strains were confirmed by complete genome sequencing. RESULTS: The overall HIV-1 prevalence was 16.6% [95% confidence interval (CI), 15.3-17.9] within the cohort. HIV-1 prevalence was higher among women, and in urban areas. Recruitment through advertisement targeted a high-risk urban male population for HIV-1 infection [adjusted odds ratio (adj. OR), 1.68; 95% CI, 1.13-2.51] when compared with men recruited door-to-door. The complexity of the HIV-1 epidemic was also higher in urban areas evidenced by the high-risk of HIV-1 infection with a recombinant strain (adj. OR, 2.69; 95% CI, 1.08-6.69) and HIV-1 dual infection (adj. OR, 5.16; 95% CI, 1.07-24.9), mainly driven by urban men recruited through advertisement. CONCLUSIONS: Overall the urban epidemic was more genetically complex, with higher prevalence and more recombinants and dual infections. Vaccine trials in Mbeya region can assess a complex HIV-1 population dynamic and determine vaccine efficacy in relationship to the genetic diversity of HIV-1 strains that challenge vaccines.
Authors: Michael J Boivin; Theodore D Ruel; Hannah E Boal; Paul Bangirana; Huyen Cao; Leigh A Eller; Edwin Charlebois; Diane V Havlir; Moses R Kamya; Jane Achan; Carolyne Akello; Joseph K Wong Journal: AIDS Date: 2010-05-15 Impact factor: 4.177
Authors: Rebecca N Koehler; Galit Alter; Sodsai Tovanabutra; Elmar Saathoff; Miguel A Arroyo; Anne M Walsh; Eric E Sanders-Buell; Leonard Maboko; Michael Hoelscher; Merlin L Robb; Nelson L Michael; Francine E McCutchan; Jerome H Kim; Gustavo H Kijak Journal: J Infect Dis Date: 2013-08-06 Impact factor: 5.226
Authors: Gustavo H Kijak; Sodsai Tovanabutra; Supachai Rerks-Ngarm; Sorachai Nitayaphan; Chirapa Eamsila; Prayura Kunasol; Chirasak Khamboonruang; Prasert Thongcharoen; Chawetsan Namwat; Nakorn Premsri; Michael Benenson; Patricia Morgan; Meera Bose; Eric Sanders-Buell; Robert Paris; Merlin L Robb; Deborah L Birx; Mark S De Souza; Francine E McCutchan; Nelson L Michael; Jerome H Kim Journal: J Virol Date: 2013-04-10 Impact factor: 5.103
Authors: F E McCutchan; M Hoelscher; S Tovanabutra; S Piyasirisilp; E Sanders-Buell; G Ramos; L Jagodzinski; V Polonis; L Maboko; D Mmbando; O Hoffmann; G Riedner; F von Sonnenburg; M Robb; D L Birx Journal: J Virol Date: 2005-09 Impact factor: 5.103
Authors: Jane P Messina; Michael Emch; Jeremie Muwonga; Kashamuka Mwandagalirwa; Samuel B Edidi; Nicaise Mama; Augustin Okenge; Steven R Meshnick Journal: Soc Sci Med Date: 2010-08-05 Impact factor: 4.634
Authors: Steffen Geis; Leonard Maboko; Elmar Saathoff; Oliver Hoffmann; Christof Geldmacher; Donan Mmbando; Eleuter Samky; Nelson L Michael; Deborah L Birx; Merlin L Robb; Michael Hoelscher Journal: J Acquir Immune Defic Syndr Date: 2011-04-15 Impact factor: 3.731
Authors: Rebecca N Koehler; Anne M Walsh; Eric E Sanders-Buell; Leigh Anne Eller; Michael Eller; Jeffrey R Currier; Christian T Bautista; Fred Wabwire-Mangen; Michael Hoelscher; Leonard Maboko; Jerome Kim; Nelson L Michael; Merlin L Robb; Francine E McCutchan; Gustavo H Kijak Journal: PLoS One Date: 2010-05-20 Impact factor: 3.240